(Q27324038)

26 June 2017

Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells (English)

1 reference

26 June 2017

29

Bart Staels

0 references

Kristina Schoonjans

26

Kristina Schoonjans

0 references

François Pattou

27

0 references

Cheryl A Brighton

Cheryl A Brighton

8

0 references

Kadiombo Bantubungi

Kadiombo Bantubungi

19

0 references

Yasmine Sebti

Yasmine Sebti

9

0 references

Hélène Dehondt

Hélène Dehondt

12

0 references

Olivier Briand

Olivier Briand

11

0 references

Nathalie Hennuyer

Nathalie Hennuyer

17

0 references

Sophie Lestavel

Sophie Lestavel

30

0 references

Anne Tailleux

Anne Tailleux

28

0 references

Robert Caiazzo

Robert Caiazzo

20

0 references

Philippe Marchetti

Philippe Marchetti

22

0 references

Fredrik Bäckhed

Fredrik Bäckhed

24

0 references

Frank Reimann

Frank Reimann

21

0 references

Fiona Gribble

Fiona M Gribble

25

0 references

Véronique Touche

5

Véronique Touche

1 reference

26 June 2017

Mohamed-Sami Trabelsi

1

Mohamed-Sami Trabelsi

1 reference

26 June 2017

2

Mehdi Daoudi

1 reference

26 June 2017

3

Janne Prawitt

1 reference

26 June 2017

4

Sarah Ducastel

1 reference

26 June 2017

13

Emmanuelle Vallez

1 reference

26 June 2017

14

Emilie Dorchies

1 reference

26 June 2017

23

Philippe Lefebvre

1 reference

26 June 2017

Sama I Sayin

6

1 reference

26 June 2017

Alessia Perino

7

1 reference

26 June 2017

Jérôme Kluza

10

1 reference

26 June 2017

Grégory Baud

15

1 reference

26 June 2017

Valeria Spinelli

16

1 reference

26 June 2017

Sandrine Caron

18

1 reference

26 June 2017

François Pattou

27

1 reference

26 June 2017

language of work or name

English

0 references

publication date

2 July 2015

1 reference

26 June 2017

Nature Communications

1 reference

26 June 2017

6

1 reference

26 June 2017

7629

1 reference

describes a project that uses

26 June 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC4579574/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

cites work

Bile acid sequestration reduces plasma glucose levels in db/db mice by increasing its metabolic clearance rate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

A G protein-coupled receptor responsive to bile acids

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

FXR is a molecular target for the effects of vertical sleeve gastrectomy

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Glucose regulates the expression of the farnesoid X receptor in liver

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Biology of incretins: GLP-1 and GIP

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Nuclear bile acid signaling through the farnesoid X receptor

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Beyond intestinal soap--bile acids in metabolic control.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Glucose-lowering effects of intestinal bile acid sequestration through enhancement of splanchnic glucose utilization

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Ageing Fxr deficient mice develop increased energy expenditure, improved glucose control and liver damage resembling NASH

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Novel insights into ChREBP regulation and function.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Transformation of postingestive glucose responses after deletion of sweet taste receptor subunits or gastric bypass surgery

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

TGR5 potentiates GLP-1 secretion in response to anionic exchange resins

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Predominant role of active versus facilitative glucose transport for glucagon-like peptide-1 secretion.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

PPARβ/δ activation induces enteroendocrine L cell GLP-1 production

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Bile acid sequestrants: glucose-lowering mechanisms

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

TGR5-mediated bile acid sensing controls glucose homeostasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Role of bile acids and bile acid receptors in metabolic regulation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Glucose sensing in L cells: a primary cell study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Bile acid sequestrants and the treatment of type 2 diabetes mellitus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Characterization and functional role of voltage gated cation conductances in the glucagon-like peptide-1 secreting GLUTag cell line.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Microbial modulation of energy availability in the colon regulates intestinal transit

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4579574

Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice

2 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8629

Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8629

Glucose sensing O-GlcNAcylation pathway regulates the nuclear bile acid receptor farnesoid X receptor (FXR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8629

Molecular mechanisms of glucose-stimulated GLP-1 secretion from perfused rat small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8629

Transgenic Mice Expressing Human Fibroblast Growth Factor-19 Display Increased Metabolic Rate and Decreased Adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8629

Loss of Cyp8b1 improves glucose homeostasis by increasing GLP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8629

The regulation of K- and L-cell activity by GLUT2 and the calcium-sensing receptor CasR in rat small intestine

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26134028

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Reduced incretin effect in type 2 (non-insulin-dependent) diabetes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26134028

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NCOMMS8629

1 reference

Dimensions Publication ID

26 June 2017

0 references

1051156147

0 references

Fatcat ID

release_rpgvl557ifbajn2bpkfank7k2e

0 references

OpenCitations bibliographic resource ID

1394571

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference